Cover image of the article: Is the Reduced Incidence of Crimean-Congo Hemorrhagic Fever Related to the Preventive Measures of COVID-19?

Image Credit:Arch Clin Infect Dis

Is the Reduced Incidence of Crimean-Congo Hemorrhagic Fever Related to the Preventive Measures of COVID-19?

Authors

Jalil NejatiJalil Nejati ORCID1, Abedin SaghafipourAbedin Saghafipour ORCID2,*
1Health Promotion Research Center, Zahedan University of Medical University Sciences, Zahedan, Iran
2Departmentof Public Health, Faculty of Health, Qom University of Medical Sciences, Qom, Iran
*Corresponding Author: Department of Public Health, School of Public Health, Qom University of Medical Sciences, Qom, Iran. Email: abed.saghafi@yahoo.com

Archives of Clinical Infectious Diseases:Vol. 16, issue 5; e109182
Published online:Dec 09, 2021
Article type:Letter
Received:Sep 07, 2020
Accepted:Nov 28, 2021
How to Cite:Nejati J, Saghafipour A. Is the Reduced Incidence of Crimean-Congo Hemorrhagic Fever Related to the Preventive Measures of COVID-19?. Arch Clin Infect Dis. 2021;16(5):e109182. doi: https://doi.org/10.5812/archcid.109182

Dear Editor,
Every year during summer, the conditions become favorable for the incidence of Crimean-Congo hemorrhagic fever (CCHF) in many areas of Iran, including Sistan and Baluchestan Province (1). The CCHF virus is naturally transmitted by hard-bodied tick from the genus Hyalomma, although other tick species have been also implicated in the natural transmission cycle. Importantly, this virus can be transmitted through eggs (transovarian transmission) or in different stages of transstadial transmission. Therefore, if the presence of infected ticks is reported in an area, it is important to observe disease transmission between the livestock and humans (2). Viremia in domestic ruminants, such as the cattle, sheep, and goats, remains for one week after infection when the animal has no obvious symptoms. During this period, disease can be transmitted to humans through the blood and viscera of infected animals and even raw animal products. Contact with the patient’s blood or tissues can also transmit the disease, especially among the hospital personnel (3).
In Iran, one of the endemic foci of CCHF is Sistan and Baluchestan Province (1). In recent years, about 40% of patients with CCHF in Iran have been reported in this province (4). This year, despite the COVID-19 outbreak, the number of suspected and confirmed cases of CCHF has significantly decreased compared to the last year in this province. In the first five months of 2019, a total of 91 suspected cases and 33 confirmed cases were reported in this province. However, since the beginning of 2020, only one case of CCHF has been reported in this area. Because the general and early symptoms of CCHF, including fever, headache, weakness, lethargy, fatigue, muscle pain, sore throat, nausea and vomiting, and diarrhea (5), are very similar to the early symptoms of COVID-19 (6), if a patient with CCHF is referred to a hospital, there may be a misdiagnosis of COVID-19, which can be very risky for the patient. It seems that part of the significant reduction in the incidence of CCHF is due to the reduced exposure of people to livestock and ticks, besides reduced exchange and livestock trafficking during the pandemic. Also, part of this reduction can be related to people’s reduced willingness to attend healthcare centers to avoid the possibility of COVID-19.
During the COVID-19 pandemic, voluntary and mandatory health protocols, such as the use of face masks and social distancing, have been observed. Obviously, there have been changes in the public’s health behaviors and adherence to hygienic standards, such as disinfection of human and animal places, regular hand washing, and use of gloves. It seems that these changes have resulted in a change in people’s health habits and reduced the incidence of CCHF during the COVID-19 pandemic in this endemic focus. However, it is recommended that until the end of the COVID-19 pandemic, physicians and healthcare professionals consider the possibility of CCHF in people with suspicious symptoms of CCHF, especially in endemic foci of this disease.

Footnotes

  • Authors' Contribution: Abedin Saghafipour designed this letter to the editor and wrote the draft. Jalil Nejati edited the manuscript.and wrote the draft and Jalil Nejati edited it.

  • Conflict of Interests: There was no conflict of interest.

  • Funding/Support: There was no financial support.

References

  • 1.
    Izadi S, Holakouie-Naieni K, Majdzadeh SR, Chinikar S, Nadim A, Rakhshani F, et al. Seroprevalence of Crimean-Congo hemorrhagic fever in Sistan-va-Baluchestan province of Iran. Jpn J Infect Dis. 2006;59(5):326-8. [PubMed ID: 17060701].
  • 2.
    Appannanavar SB, Mishra B. An update on crimean congo hemorrhagic Fever. J Glob Infect Dis. 2011;3(3):285-92. [PubMed ID: 21887063]. [PubMed Central ID: PMC3162818]. https://doi.org/10.4103/0974-777X.83537.
  • 3.
    Clements AC, Spengler JR, Bergeron É, Rollin PE. Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals. PLOS Negl Trop Dis. 2016;10(1). https://doi.org/10.1371/journal.pntd.0004210.
  • 4.
    Keshtkar-Jahromi M, Sajadi MM, Ansari H, Mardani M, Holakouie-Naieni K. Crimean-Congo hemorrhagic fever in Iran. Antiviral Res. 2013;100(1):20-8. [PubMed ID: 23872313]. [PubMed Central ID: PMC4260932]. https://doi.org/10.1016/j.antiviral.2013.07.007.
  • 5.
    World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for front-line health workers: interim emergency guidance for country adaptation. World Health Organization; 2016.
  • 6.
    Ahmadi A, Fadai Y, Shirani M, Rahmani F. Modeling and forecasting trend of COVID-19 epidemic in Iran until May 13, 2020. Med J Islam Repub Iran. 2020. https://doi.org/10.47176/mjiri.34.27.

Copyright

Copyright © 2021, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Similar Articles

25
Jan
2014
Crimean-Congo Hemorrhagic Fever: A Reemerging Disease

Crimean-Congo Hemorrhagic Fever: A Reemerging Disease

Maliheh Metanat,
Batool Sharifi Mood,
Salehi Masoud

Metanat M, Sharifi Mood B, Masoud S. Crimean-Congo Hemorrhagic Fever: A Reemerging Disease. Arch Clin Infect Dis. 2014;9(1):e20568. doi: https://doi.org/10.5812/archcid.20568

20
Jul
2014
Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies

Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies

Maryam Keshtkar Jahromi

Jahromi MK. Crimean-Congo Hemorrhagic Fever-Treatment and Preventive Strategies. Int J Infect. 2014;1(2):e20310. doi: https://doi.org/10.17795/iji-20310

30
Nov
2011

Optional Modalities for Treatment of Patients with Severe Crimean-Congo Hemorrhagic Fever

Batool Sharifi Mood,
Maliheh Metanat,
Roya Alavi Naini,
Masoud Mardani,
Ali Amjadi

Sharifi Mood B, Metanat M, Alavi Naini R, Mardani M, Amjadi A. Optional Modalities for Treatment of Patients with Severe Crimean-Congo Hemorrhagic Fever. Arch Clin Infect Dis. 2011;6(Suppl):. doi:

27
Nov
2023
A Case Report of Crimean-Congo Hemorrhagic Fever in Iran

A Case Report of Crimean-Congo Hemorrhagic Fever in Iran

Mohamad Zeinali,
Sara Doosti,
Behzad Amiri,
Gidiglo Nutifafa Godwin,
Roknedin Mehdizad

Zeinali M, Doosti S, Amiri B, Godwin GN, Mehdizad R. A Case Report of Crimean-Congo Hemorrhagic Fever in Iran. Arch Clin Infect Dis. 2023;18(5):e132680. doi: https://doi.org/10.5812/archcid-132680

17
Jun
2019
An Overview of Complications and Mortality of Crimean-Congo Hemorrhagic Fever

An Overview of Complications and Mortality of Crimean-Congo Hemorrhagic Fever

Hamidreza Kouhpayeh

Kouhpayeh H. An Overview of Complications and Mortality of Crimean-Congo Hemorrhagic Fever. Int J Infect. 2019;6(2):e91707. doi: https://doi.org/10.5812/iji.91707

More by these authors

Jalil NejatiPubMedScholar
Abedin SaghafipourPubMedScholar
Share
Cited by
Metrics